William Devaul News Today

Shares of Morphic Holding, Inc. (NASDAQ:MORF – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average […]

Morphic Holding, Inc. (NASDAQ:MORF – Get Free Report) General Counsel William Devaul sold 4,509 shares of Morphic stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $27.49, for a total value of $123,952.41. Following the completion of the sale, the general counsel now owns 23,029 shares in […]

Berenberg Bank started coverage on shares of Morphic (NASDAQ:MORF – Get Free Report) in a research note issued on Friday, FlyOnTheWall reports. The firm set a “buy” rating on the stock. Other equities analysts also recently issued reports about the company. Royal Bank of Canada boosted their price objective on Morphic from $75.00 to $80.00 […]

Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) General Counsel William Devaul sold 7,756 shares of the company’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $60.05, for a total value of $465,747.80. Following the completion of the transaction, the general counsel now directly owns 13,338 shares […]

Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) General Counsel William Devaul sold 3,802 shares of Morphic stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $60.03, for a total transaction of $228,234.06. Following the sale, the general counsel now owns 21,194 shares of the company’s stock, valued […]